Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy-Reference-Cited by-同舟云学术

Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy

Published:2007-01 Issue:5 Volume:120 Page:663-669
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Partington Sara L.,Abid Simona,Teo Koon,Oczkowski Wesley,O'Donnell Martin J.

Publisher

Elsevier BV

Subject

Hematology

Reference22 articles.

1. Epidemiologic features of chronic atrial fibrillation: the Framingham Study;Kannel;N Engl J Med,1982

2. Atrial fibrillation as an independent risk factor for stroke;Wolf;Stroke,1991

3. Antithrombic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis;Hart;Ann Intern Med,1999

4. Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation,1998

5. Why do patients with atrial fibrillation not receive warfarin?;Bungard;Arch Intern Med,2000

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New oral anticoagulants in nonvalvular atrial fibrillation;Galenika Medical Journal;2022

2. Use of oral anticoagulants and its associated factors among nonvalvular atrial fibrillation patients with new‐onset acute ischemic stroke: A report from the China Atrial Fibrillation Registry study;Clinical Cardiology;2021-12-24

3. Barriers and facilitators to optimal oral anticoagulant management: a scoping review;Journal of Thrombosis and Thrombolysis;2020-02-10

4. Stroke prevention in atrial fibrillation: Closing the gap;American Heart Journal;2019-04

5. Optimal choice of pharmacological therapy – Prevention of stroke and assessment of bleeding risk in patients with atrial fibrillation;International Journal of Preventive Medicine;2019